Trials / Completed
CompletedNCT03165253
The Effects of a Synbiotic Addition on Eradication Therapy of Helicobacter Pylori Infection in Children
The Effects of the Synbiotic "Bifidobacterium Lactis B94 Plus Inulin" Addition on Standard Triple Therapy of Helicobacter Pylori Eradication in Children
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 69 (actual)
- Sponsor
- Bulent Ecevit University · Academic / Other
- Sex
- All
- Age
- 6 Years – 16 Years
- Healthy volunteers
- Not accepted
Summary
The aim of the study is to evaluate the effects of the synbiotic Bifidobacterium animalis ssp. lactis B94 plus inulin addition to the standard triple therapy on Helicobacter pylori infection eradication rates in children.
Detailed description
The study aims to evaluate the effects of the synbiotic Bifidobacterium animalis ssp. lactis B94 plus inulin addition to the standard triple therapy on the eradication rates of Helicobacter pylori (H. pylori) infection in children. The subjects are children between 6 to 16 years old who had biopsy proven H. pylori infection. The subjects will be randomly classified into two groups. The first group will receive the standard triple therapy consisting of amoxicillin oral tablet (50 mg/kg/day) + clarithromycin oral tablet (15 mg/kg/day) + omeprazole oral capsule (1mg/kg/day). The second group will receive the standard triple therapy and Bifidobacterium animalis ssp. lactis B94 (5000000000 colony forming units/dose) plus inulin (900 mg) containing sachet for 14 days, concurrently. Eradication will be determined by 14-Carbon-urea breath test 4-6 weeks after therapy discontinuation. The eradication rates, the occurrence of side effects and the alterations of initial symptoms will be compared between the groups.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Bifidobacterium Animalis Oral Product | The synbiotic group will receive this product. |
| DRUG | Amoxicillin Oral Tablet | 50mg/kg/day B.I.D. |
| DRUG | Clarithromycin Oral Tablet | 15 mg/kg/day B.I.D. |
| DRUG | Omeprazole | 1 mg/kg/day |
Timeline
- Start date
- 2011-06-01
- Primary completion
- 2012-06-01
- Completion
- 2012-08-01
- First posted
- 2017-05-24
- Last updated
- 2017-05-24
Source: ClinicalTrials.gov record NCT03165253. Inclusion in this directory is not an endorsement.